The immune cell landscape in kidneys of patients with lupus nephritis
-
Published:2019-06-17
Issue:7
Volume:20
Page:902-914
-
ISSN:1529-2908
-
Container-title:Nature Immunology
-
language:en
-
Short-container-title:Nat Immunol
Author:
Arazi Arnon, , Rao Deepak A., Berthier Celine C., Davidson Anne, Liu Yanyan, Hoover Paul J., Chicoine Adam, Eisenhaure Thomas M.ORCID, Jonsson A. Helena, Li Shuqiang, Lieb David J.ORCID, Zhang Fan, Slowikowski Kamil, Browne Edward P., Noma Akiko, Sutherby Danielle, Steelman Scott, Smilek Dawn E., Tosta Patti, Apruzzese William, Massarotti Elena, Dall’Era Maria, Park Meyeon, Kamen Diane L., Furie Richard A., Payan-Schober Fernanda, Pendergraft William F., McInnis Elizabeth A., Buyon Jill P.ORCID, Petri Michelle A., Putterman ChaimORCID, Kalunian Kenneth C., Woodle E. Steve, Lederer James A., Hildeman David A.ORCID, Nusbaum Chad, Raychaudhuri Soumya, Kretzler MatthiasORCID, Anolik Jennifer H., Brenner Michael B.ORCID, Wofsy David, Hacohen NirORCID, Diamond BettyORCID
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference59 articles.
1. Costenbader, K. H. et al. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 63, 1681–1688 (2011). 2. Narain, S. & Furie, R. Update on clinical trials in systemic lupus erythematosus. Curr. Opin. Rheumatol. 28, 477–487 (2016). 3. Tektonidou, M. G., Dasgupta, A. & Ward, M. M. Risk of end-stage renal disease in patients with lupus nephritis, 1971–2015: a systematic review and Bayesian meta-analysis. Arthritis Rheumatol. 68, 1432–1441 (2016). 4. Thanou, A. & Merrill, J. T. Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys. Nat. Rev. Rheumatol. 10, 23–34 (2014). 5. Banchereau, R. et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165, 1548–1550 (2016).
Cited by
546 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|